Short answer
NovoCure Ltd (NVCR) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 and full-year fiscal 2025 earnings released February 26, 2026; details in Exhibit 99.1.
NovoCure Ltd 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year fiscal 2025 earnings released February 26, 2026; details in Exhibit 99.1
- Investor action required: refer to attached press release for revenue, margins, and guidance figures
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NovoCure Ltd 8-K filings
Get the next NVCR 8-K as it lands
Follow NVCR for push alerts, or ask the research agent what this filing means.